1932

Abstract

The role for HLA typing in autoimmune disease is changing with the recognition that HLA markers can identify patients with poor prognosis in some autoimmune disease. Aggressive therapeutic intervention in patients with such HLA prognostic markers has the potential to improve or prevent progressive disease outcomes in a select group of patients.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.med.46.1.17
1995-02-01
2024-06-22
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.med.46.1.17
Loading
/content/journals/10.1146/annurev.med.46.1.17
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error